683 Capital Management’s Calidi Biotherapeutics CLDI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-316
| Closed | -$4.32K | – | 214 |
|
|
2024
Q3 | $4.32K | Hold |
316
| – | – | ﹤0.01% | 118 |
|
|
2024
Q2 | $7.58K | Sell |
316
-84
| -21% | -$2.01K | ﹤0.01% | 117 |
|
|
2024
Q1 | $27.1K | Buy |
+400
| New | +$27.1K | ﹤0.01% | 99 |
|
|
2023
Q3 | – | Sell |
-2,500
| Closed | -$3.15M | – | 139 |
|
|
2023
Q2 | $3.15M | Hold |
2,500
| – | – | 0.23% | 66 |
|
|
2023
Q1 | $3.08M | Hold |
2,500
| – | – | 0.23% | 83 |
|
|
2022
Q4 | $3.05M | Hold |
2,500
| – | – | 0.26% | 79 |
|
|
2022
Q3 | $2.96M | Sell |
2,500
-7,500
| -75% | -$8.87M | 0.23% | 83 |
|
|
2022
Q2 | $11.9M | Hold |
10,000
| – | – | 0.84% | 37 |
|
|
2022
Q1 | $11.9M | Buy |
10,000
+8,333
| +500% | +$9.89M | 0.64% | 38 |
|
|
2021
Q4 | $1.96M | Buy |
+1,667
| New | +$1.96M | 0.07% | 128 |
|